# AI-Enabled Precision Echocardiography: Toward Personalized Cardiovascular Care

**Authors:** Lamia Al Saikhan

PMC · DOI: 10.3390/diagnostics16050694 · Diagnostics · 2026-02-26

## TL;DR

AI is transforming echocardiography by enabling personalized cardiovascular assessments that consider individual patient data for better diagnosis and treatment.

## Contribution

The paper introduces AI-enabled precision echocardiography as a new approach to cardiovascular care by integrating patient-specific data.

## Key findings

- AI can improve targeted therapy selection for heart failure with preserved ejection fraction.
- AI enables individualized cardiotoxicity risk prediction in cardio-oncology.
- AI supports personalized sudden cardiac death prevention in cardiomyopathy.

## Abstract

Conventional echocardiography traditionally relies on population-derived reference values and dichotomous classification schemes that do not fully account for individual patient characteristics or disease complexity. Artificial intelligence (AI) is driving a paradigm shift toward precision echocardiography by enabling patient-specific cardiovascular assessment through the integration of phenotypic, clinical, and biological data. This review examines how AI is transforming echocardiography from a population-based test into a patient-specific assessment tool that supports precision cardiovascular care. It highlights three clinical applications with potential clinical impact: Heart Failure with Preserved Ejection Fraction phenogrouping for targeted therapy selection, cardio-oncology surveillance with individualized cardiotoxicity risk prediction, and cardiomyopathy risk stratification for personalized sudden cardiac death prevention. For each application, it describes the clinical challenge, the AI-enabled precision solution, and its potential clinical impact. It also outlines a practical roadmap for clinical adoption. Precision echocardiography, powered by AI, holds promise for transforming cardiovascular imaging and diagnostics by enabling more patient-specific assessment, earlier disease detection, and personalized therapeutic strategies.

## Linked entities

- **Diseases:** heart failure (MONDO:0005252), cardiomyopathy (MONDO:0004994)

## Full-text entities

- **Diseases:** sudden cardiac death (MESH:D016757), cardiotoxicity (MESH:D066126), Heart Failure (MESH:D006333), cardiomyopathy (MESH:D009202)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12984559/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12984559/full.md

## References

80 references — full list in the complete paper: https://tomesphere.com/paper/PMC12984559/full.md

---
Source: https://tomesphere.com/paper/PMC12984559